Li Tang
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Immunology top 1%
- Immunotherapy and Immune Responses
Papers in
-
- RNA Interference and Gene Delivery 18
- Oncology 42
- CAR-T cell therapy research 18
- Co-authors
- Jianjun Cheng (29 shared papers)Timothy M. Fan (10 shared papers)Qian Yin (16 shared papers)Darrell J. Irvine (8 shared papers)Yuqing Xie (7 shared papers)C. Richard Hutchinson (8 shared papers)Kewen Lei (6 shared papers)Rong Tong (13 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (4 papers)Biomaterials Science (3 papers)ACS Nano (3 papers)Journal of Medical Virology (3 papers)The Journal of Antibiotics (3 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Li Tang
188 papers receiving 9.2k citations
Li Tang's Hit Papers
Peers
Comparison fields: 5 of 170
- Biomaterials 2.0k
- Immunology 1.8k
- Pharmacology 1.2k
- Biomedical Engineering 2.5k
- Oncology 1.4k
Countries citing papers authored by Li Tang
This map shows the geographic impact of Li Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Tang more than expected).
Fields of papers citing papers by Li Tang
This network shows the impact of papers produced by Li Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Tang. The network helps show where Li Tang may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 191 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Investigating the optimal size of anticancer nanomedicine Hit paper breakdown → | 2014 | 583 |
| 2 | Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery Hit paper breakdown → | 2018 | 568 |
| 3 | 2013 | 417 | |
| 4 | Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion Hit paper breakdown → | 2020 | 391 |
| 5 | 2000 | 371 | |
| 6 | 1998 | 305 | |
| 7 | 2011 | 289 | |
| 8 | 2006 | 200 | |
| 9 | 2021 | 189 | |
| 10 | 2009 | 189 | |
| 11 | 2012 | 179 | |
| 12 | IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases Hit paper breakdown → | 2024 | 175 |
| 13 | 2013 | 175 | |
| 14 | 2014 | 172 | |
| 15 | 2013 | 162 | |
| 16 | 2013 | 158 | |
| 17 | 2015 | 154 | |
| 18 | 2021 | 140 | |
| 19 | 2013 | 136 | |
| 20 | 2020 | 132 |
About Li Tang
Li Tang is a scholar working on Molecular Biology, Oncology, Immunology, Biomedical Engineering and Biomaterials, having authored 191 papers that have together received 9.3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (26 papers), Microbial Natural Products and Biosynthesis (20 papers), Immunotherapy and Immune Responses (19 papers), Nanoplatforms for cancer theranostics (19 papers), RNA Interference and Gene Delivery (18 papers), CAR-T cell therapy research (18 papers), Graphene and Nanomaterials Applications (12 papers) and Cancer Research and Treatments (8 papers). The work is most often cited by research in Biomaterials (2.0k citations), Immunology (1.8k citations), Pharmacology (1.2k citations), Biomedical Engineering (2.5k citations) and Oncology (1.4k citations). Li Tang has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Jianjun Cheng, Timothy M. Fan, Qian Yin, Darrell J. Irvine, Yuqing Xie, C. Richard Hutchinson, Kewen Lei, Rong Tong, Yugang Guo and Luke B. Borst. Their work appears in journals such as Proceedings of the National Academy of Sciences, Biomaterials Science, ACS Nano, Journal of Medical Virology and The Journal of Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.